Sign In
Buy LZAGY
$69.59
-1.55 (-2.18%)
At Close: Jul 31, 2026
Lonza Group AG (LZAGY) Q1 2025 Earnings Call Transcript
01:27pm, Friday, 09'th May 2025
Lonza Group AG (OTCPK:LZAGY) Q1 2025 Earnings Conference Call May 9, 2025 9:00 AM ET Company Participants Philippe Deecke - Chief Financial Officer Conference Call Participants Zain Ebrahim - JPMorgan
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy?
01:05pm, Tuesday, 06'th May 2025
Does Lonza Group Ag (LZAGY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know
01:05pm, Tuesday, 08'th Apr 2025
Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Lonza: Well Equipped In The U.S., Buy Confirmed
03:43am, Saturday, 05'th Apr 2025
Sustainable high market growth ahead with supportive margin recovery. There are limited tariff risks. Lonza is a potential beneficiary given the ample availability of the USA industrial capacities sho
NVST or LZAGY: Which Is the Better Value Stock Right Now?
12:51pm, Wednesday, 01'st Jan 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Lonza Group Ag (LZAGY). But which of these two stocks presents investors with the be
New Strong Sell Stocks for December 23rd
02:11am, Monday, 23'rd Dec 2024
CENTA, IDEXY and LZAGY have been added to the Zacks Rank #5 (Strong Sell) List on December 23, 2024.
AHCO or LZAGY: Which Is the Better Value Stock Right Now?
12:45pm, Thursday, 24'th Oct 2024
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?
AHCO vs. LZAGY: Which Stock Is the Better Value Option?
12:48pm, Tuesday, 08'th Oct 2024
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Lonza Group Ag (LZAGY). But which of these two companies is the best option for those
All You Need to Know About Lonza Group (LZAGY) Rating Upgrade to Strong Buy
01:00pm, Monday, 02'nd Sep 2024
Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Lonza Group AG (LZAGY) Q2 2024 Earnings Call Transcript
09:26pm, Thursday, 25'th Jul 2024
Lonza Group AG (OTCPK:LZAGY) Q2 2024 Earnings Conference Call July 25, 2024 7:00 AM ET Company Participants Wolfgang Wienand - Chief Executive Officer Philippe Deecke - Chief Financial Officer Confere
ESLOY or LZAGY: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 18'th Jul 2024
Investors with an interest in Medical - Products stocks have likely encountered both EssilorLuxottica Unsponsored ADR (ESLOY) and Lonza Group Ag (LZAGY). But which of these two companies is the best o
LZAGY, DSDVY: Investment Opportunities Outside of the U.S.
05:42pm, Wednesday, 10'th Jul 2024
U.S. equity markets have benefitted from a perceived quality advantage over Europe, though it's uncertain when outperformance will end, notes Bryan Lee. He discusses finding investment opportunities o
Lonza Group AG (LZAGY) Q1 2024 Earnings Call Transcript
01:48pm, Tuesday, 14'th May 2024
Lonza Group AG (OTCPK:LZAGY) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET Company Participants Albert Baehny - Interim Chief Executive Officer & Chairman of the Board of Directors Philippe
Lonza: Acceleration In Mid-Term Sales Growth
01:20pm, Thursday, 04'th Apr 2024
Reflecting Lonza's Vacaville acquisition, we increased our sales and EBITDA expectations. The company has an ongoing buyback and a progressive dividend per share. We positively view the new CEO appoin
Lonza: Excellent Growth Projections Will Sharply Increase Free Cash Flow
10:40am, Saturday, 27'th Jan 2024
Lonza Group aims to increase revenue by double digits by 2028 through aggressive expansion in the CDMO space. Lonza expects to increase its EBITDA margin to 32%-34% by 2028 and maintain a low debt rat
